Open Access

Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report

  • Authors:
    • Tomohito Shinoda
    • Toshiyuki Tanahashi
    • Takuji Sakuratani
    • Masato Ota
    • Seito Fujibayashi
    • Shunya Kiriyama
    • Keita Matsumoto
    • Kazunori Yawata
    • Yoshiyuki Sasaki
    • Shinji Osada
    • Makoto Yamada
  • View Affiliations

  • Published online on: November 14, 2021     https://doi.org/10.3892/mco.2021.2441
  • Article Number: 11
  • Copyright: © Shinoda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer was achieved. A 72‑year‑old man was diagnosed with gastric adenocarcinoma with multiple liver metastases. The patient's general condition was good, with an Eastern Cooperative Oncology Group performance status of 1. Chemotherapy with oxaliplatin and S‑1 was initiated and, after four cycles, the patient noticed sudden abdominal distension. Despite the marked regression of the liver metastases, massive ascites, segmental atrophy and esophageal varices developed, findings consistent with pseudocirrhosis. The patient achieved complete response for the primary and metastatic lesions. Following endoscopic ligation of the varices, he underwent subsequent chemotherapy with S‑1 only and management of his ascites for 6 months. At 12 months after initial chemotherapy, the patient appeared to be disease‑free. In conclusion, clinicians should be aware of the possibility of pseudocirrhosis in cases of cancer metastasis to the liver, including metastatic gastric cancer.
View Figures
View References

Related Articles

Journal Cover

January-2022
Volume 16 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shinoda T, Tanahashi T, Sakuratani T, Ota M, Fujibayashi S, Kiriyama S, Matsumoto K, Yawata K, Sasaki Y, Osada S, Osada S, et al: Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report. Mol Clin Oncol 16: 11, 2022
APA
Shinoda, T., Tanahashi, T., Sakuratani, T., Ota, M., Fujibayashi, S., Kiriyama, S. ... Yamada, M. (2022). Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report. Molecular and Clinical Oncology, 16, 11. https://doi.org/10.3892/mco.2021.2441
MLA
Shinoda, T., Tanahashi, T., Sakuratani, T., Ota, M., Fujibayashi, S., Kiriyama, S., Matsumoto, K., Yawata, K., Sasaki, Y., Osada, S., Yamada, M."Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report". Molecular and Clinical Oncology 16.1 (2022): 11.
Chicago
Shinoda, T., Tanahashi, T., Sakuratani, T., Ota, M., Fujibayashi, S., Kiriyama, S., Matsumoto, K., Yawata, K., Sasaki, Y., Osada, S., Yamada, M."Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report". Molecular and Clinical Oncology 16, no. 1 (2022): 11. https://doi.org/10.3892/mco.2021.2441